An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)
- Authors:
- Kuan Gao
- Xinyang Li
- Shuya Luo
- Limei Zhao
-
Affiliations: Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Department of Ion Channel Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, P.R. China - Published online on: March 21, 2024 https://doi.org/10.3892/ijo.2024.5639
- Article Number: 51
-
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T and Zare P: Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. 18:592020. View Article : Google Scholar : PubMed/NCBI | |
|
Quail DF and Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med. 19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hanahan D and Coussens LM: Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kelly L, McGrath S, Rodgers L, McCall K, Tulunay Virlan A, Dempsey F, Crichton S and Goodyear CS: Annexin-A1: The culprit or the solution? Immunology. 166:2–16. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Foo SL, Yap G, Cui J and Lim LHK: Annexin-A1-A Blessing or a curse in cancer? Trends Mol Med. 25:315–327. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Deng C, Liu X, Zhang C, Li L, Wen S, Gao X and Liu L: ANXA1GSK3beta interaction and its involvement in NSCLC metastasis. Acta Biochim Biophys Sin (Shanghai). 53:912–924. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu JF, Huang W, Yi HM, Xiao T, Li JY, Feng J, Yi H, Lu SS, Li XH, Lu RH, et al: Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation. Cell Death Dis. 9:11542018. View Article : Google Scholar : PubMed/NCBI | |
|
Novizio N, Belvedere R, Morretta E, Tomasini R, Monti MC, Morello S and Petrella A: Role of intracellular and extracellular annexin A1 in MIA PaCa-2 spheroids formation and drug sensitivity. Cancers (Basel). 14:47642022. View Article : Google Scholar : PubMed/NCBI | |
|
Foo SL, Sachaphibulkij K, Lee CLY, Yap GLR, Cui J, Arumugam T and Lim LHK: Breast cancer metastasis to brain results in recruitment and activation of microglia through annexin-A1/formyl peptide receptor signaling. Breast Cancer Res. 24:252022. View Article : Google Scholar : PubMed/NCBI | |
|
Khau T, Langenbach SY, Schuliga M, Harris T, Johnstone CN, Anderson RL and Stewart AG: Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J. 25:483–496. 2011. View Article : Google Scholar | |
|
Novizio N, Belvedere R, Pessolano E, Morello S, Tosco A, Campiglia P, Filippelli A and Petrella A: ANXA1 contained in EVs regulates macrophage polarization in tumor microenvironment and promotes pancreatic cancer progression and metastasis. Int J Mol Sci. 22:110182021. View Article : Google Scholar : PubMed/NCBI | |
|
Vecchi L, Alves Pereira Zóia M, Goss Santos T, de Oliveira Beserra A, Colaço Ramos CM, França Matias Colombo B, Paiva Maia YC, Piana de Andrade V, Teixeira Soares Mota S, Gonçalves de Araújo T, et al: Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo. Biochim Biophys Acta Mol Cell Res. 1865:1368–1382. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Geary LA, Nash KA, Adisetiyo H, Liang M, Liao CP, Jeong JH, Zandi E and Roy-Burman P: CAF-Secreted Annexin A1 induces prostate cancer cells to gain stem cell-like features. Mol Cancer Res. 12:607–621. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fu Z, Zhang S, Wang B, Huang W, Zheng L and Cheng A: Annexin A1: A double-edged sword as novel cancer biomarker. Clin Chim Acta. 504:36–42. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Mizuno H, Uemura K, Moriyama A, Wada Y, Asai K, Kimura S and Kato T: Glucocorticoid induced the expression of mRNA and the secretion of lipocortin 1 in rat astrocytoma cells. Brain Res. 746:256–264. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Gimenes AD, Andrade TR, Mello CB, Ramos L, Gil CD and Oliani SM: Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis. Exp Eye Res. 134:24–32. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ricci E, Ronchetti S, Pericolini E, Gabrielli E, Cari L, Gentili M, Roselletti E, Migliorati G, Vecchiarelli A and Riccardi C: Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression. FASEB J. 31:3054–3065. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Castro-Caldas M, Mendes AF, Duarte CB and Lopes MC: Dexamethasone-induced and estradiol-induced CREB activation and annexin 1 expression in CCRF-CEM lymphoblastic cells: Evidence for the involvement of cAMP and p38 MAPK. Mediators Inflamm. 12:329–337. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Solito E, de Coupade C, Parente L, Flower RJ and Russo-Marie F: IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine. 10:514–521. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Vecchi L, Mota STS, Zoia MAP, Martins IC, de Souza JB, Santos TG, Beserra AO, de Andrade VP, Goulart LR and Araujo TG: Interleukin-6 signaling in triple negative breast cancer cells elicits the annexin A1/Formyl peptide receptor 1 axis and affects the tumor microenvironment. Cells. 11:17052022. View Article : Google Scholar : PubMed/NCBI | |
|
Soler MF, Abaurrea A, Azcoaga P, Araujo AM and Caffarel MM: New perspectives in cancer immunotherapy: Targeting IL-6 cytokine family. J Immunother Cancer. 11:e0075302023. View Article : Google Scholar : PubMed/NCBI | |
|
Rupaimoole R and Slack FJ: MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Y, Anbalagan D, Lee LH, Samy RP, Shanmugam MK, Kumar AP, Sethi G, Lobie PE and Lim LH: ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation. Oncotarget. 7:27007–27020. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Suh YE, Raulf N, Gäken J, Lawler K, Urbano TG, Bullenkamp J, Gobeil S, Huot J, Odell E and Tavassoli M: MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance. Int J Cancer. 137:1021–1034. 2015. View Article : Google Scholar | |
|
Hu C, Peng J, Lv L, Wang X, Zhou Y, Huo J and Liu D: miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1. Oncol Lett. 17:5201–5209. 2019.PubMed/NCBI | |
|
Boudhraa Z, Bouchon B, Viallard C, D'Incan M and Degoul F: Annexin A1 localization and its relevance to cancer. Clin Sci (Lond). 130:205–220. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hoque M, Rentero C, Cairns R, Tebar F, Enrich C and Grewal T: Annexins-Scaffolds modulating PKC localization and signaling. Cell Signal. 26:1213–1225. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Solito E CH, Festa M, Mulla A, Tierney T, Flower RJ and Buckingham JC: Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J. 20:1498–1500. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Li L, Wang J, Zhang R, Zhang T, Wu Y, Wang S and Xing D: The ABCA1-efferocytosis axis: A new strategy to protect against atherosclerosis. Clin Chim Acta. 518:1–8. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Perretti M, Christian H, Wheller SK, Aiello I, Mugridge KG, Morris JF, Flower RJ and Goulding NJ: Annexin I is stored within gelatinase granules of human neutrophil and mobilized on the cell surface upon adhesion but not phagocytosis. Cell Biol Int. 24:163–174. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Leoni G, Neumann PA, Kamaly N, Quiros M, Nishio H, Jones HR, Sumagin R, Hilgarth RS, Alam A, Fredman G, et al: Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair. J Clin Invest. 125:1215–1227. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q, Liu W, Wang Z, Wang C and Ai Z: Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation. Int J Oncol. 59:1042021. View Article : Google Scholar : PubMed/NCBI | |
|
Pessolano E, Belvedere R, Bizzarro V, Franco P, Marco ID, Porta A, Tosco A, Parente L, Perretti M and Petrella A: Annexin A1 may induce pancreatic cancer progression as a key player of extracellular vesicles effects as evidenced in the in vitro MIA PaCa-2 model system. Int J Mol Sci. 19:38782018. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y, Hao H, Tang K, Yi P, Liu M, et al: Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene. 30:3887–3899. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Cooray SN, Gobbetti T, Montero-Melendez T, McArthur S, Thompson D, Clark AJ, Flower RJ and Perretti M: Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci USA. 110:18232–18237. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI | |
|
Jin KT, Yao JY, Fang XL, Di H and Ma YY: Roles of lncRNAs in cancer: Focusing on angiogenesis. Life Sci. 252:1176472020. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Ostoot FH, Salah S, Khamees HA and Khanum SA: Tumor angiogenesis: Current challenges and therapeutic opportunities. Cancer Treat Res Commun. 28:1004222021. View Article : Google Scholar : PubMed/NCBI | |
|
Yi M and Schnitzer JE: Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci USA. 106:17886–17891. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Delorme S, Privat M, Sonnier N, Rouanet J, Witkowski T, Kossai M, Mishellany F, Radosevic-Robin N, Juban G, Molnar I, et al: New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination. Am J Cancer Res. 11:1600–1615. 2021.PubMed/NCBI | |
|
Hatakeyama S, Sugihara K, Shibata TK, Nakayama J, Akama TO, Tamura N, Wong SM, Bobkov AA, Takano Y, Ohyama C, et al: Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide. Proc Natl Acad Sci USA. 108:19587–19592. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hebeda CB, Sandri S, Benis CM, Paula-Silva M, Loiola RA, Reutelingsperger C, Perretti M and Farsky SHP: Annexin A1/Formyl peptide receptor pathway controls uterine receptivity to the blastocyst. Cells. 9:11812020. View Article : Google Scholar | |
|
Dianat-Moghadam H, Nedaeinia R, Keshavarz M, Azizi M, Kazemi M and Salehi R: Immunotherapies targeting tumor vasculature: Challenges and opportunities. Front Immunol. 14:12263602023. View Article : Google Scholar : PubMed/NCBI | |
|
Côté MC, Lavoie JR, Houle F, Poirier A, Rousseau S and Huot J: Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM kinase 1-mediated phosphorylation of annexin 1. J Biol Chem. 285:8013–8021. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Anbalagan D, Yap G, Yuan Y, Pandey VK, Lau WH, Arora S, Bist P, Wong JS, Sethi G, Nissom PM, et al: Annexin-A1 regulates microRNA-26b* and microRNA-562 to directly target NF-kappaB and angiogenesis in breast cancer cells. PLoS One. 9:e1145072014. View Article : Google Scholar | |
|
Novizio N, Belvedere R, Pessolano E, Tosco A, Porta A, Perretti M, Campiglia P, Filippelli A and Petrella A: Annexin A1 released in extracellular vesicles by pancreatic cancer cells activates components of the tumor microenvironment, through interaction with the Formyl-Peptide receptors. Cells. 9:27192020. View Article : Google Scholar : PubMed/NCBI | |
|
D'Acquisto F, Perretti M and Flower RJ: Annexin-A1: A pivotal regulator of the innate and adaptive immune systems. Br J Pharmacol. 155:152–169. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Perretti M and D'Acquisto F: Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol. 9:62–70. 2009. View Article : Google Scholar | |
|
Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S and Perretti M: A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17:1–27. 2003. View Article : Google Scholar | |
|
Gavins FNE and Hickey MJ: Annexin A1 and the regulation of innate and adaptive immunity. Front Immunol. 3:3542012. View Article : Google Scholar : PubMed/NCBI | |
|
Shaul ME and Fridlender ZG: Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol. 102:343–349. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sandri S, Hebeda CB, Broering MF, de Paula Silva M, Moredo LF, de Barros E Silva MJ, Sapata Molina A, Lopes Pinto CA, Duprat Neto JP, Reutelingsperger CP, et al: Role of Annexin A1 secreted by neutrophils in melanoma metastasis. Cells. 12:4252023. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Liu Y, Yao X, Ping Y, Jiang T, Liu Q, Xu S, Huang J, Mou H, Gong W, et al: Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol. 179:1504–1512. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Moraes LA, Ampomah PB and Lim LHK: Annexin A1 in inflammation and breast cancer: A new axis in the tumor microenvironment. Cell Adh Migr. 12:417–423. 2018.PubMed/NCBI | |
|
Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR and Yang SM: Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol. 2012:9480982012. View Article : Google Scholar : PubMed/NCBI | |
|
Moraes LA, Kar S, Foo SL, Gu T, Toh YQ, Ampomah PB, Sachaphibulkij K, Yap G, Zharkova O, Lukman HM, et al: Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment. Sci Rep. 7:179252017. View Article : Google Scholar : PubMed/NCBI | |
|
Cioni B, Ratti S, Piva A, Tripodi I, Milani M, Menichetti F, Langella T, Botti L, De Cecco L, Chiodoni C, et al: JMJD6 shapes a pro-tumor microenvironment via ANXA1-dependent macrophage polarization in breast cancer. Mol Cancer Res. 21:614–627. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Song Z, Wang X, Liu X, Luo Y, Qiu J, Yin A, Liu Y, Yi H, Xiao Z and Li A: Targeting of Annexin A1 in Tumor-associated Macrophages as a therapeutic strategy for hepatocellular carcinoma. Biochem Pharmacol. 213:1156122023. View Article : Google Scholar : PubMed/NCBI | |
|
Wu L, Wu W, Zhang J, Zhao Z, Li L, Zhu M, Wu M, Wu F, Zhou F, Du Y, et al: Natural coevolution of tumor and immunoenvironment in glioblastoma. Cancer Discov. 12:2820–2837. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Han CJ, Zheng JY, Sun L, Yang HC, Cao ZQ, Zhang XH, Zheng LT and Zhen XC: The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK/mTOR/NF-κB pathway. Acta pharmacol Sin. 40:1292–1302. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Li W and Graeber MB: The molecular profile of microglia under the influence of glioma. Neuro oncol. 14:958–978. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Domogalla MP, Rostan PV, Raker VK and Steinbrink K: Tolerance through education: How tolerogenic dendritic cells shape immunity. Front Immunol. 8:17642017. View Article : Google Scholar | |
|
Linke B, Abeler-Dörner L, Jahndel V, Kurz A, Mahr A, Pfrang S, Linke L, Krammer PH and Weyd H: The tolerogenic function of annexins on apoptotic cells is mediated by the annexin core domain. J Immunol. 194:5233–5242. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Bode K, Bujupi F, Link C, Hein T, Zimmermann S, Peiris D, Jaquet V, Lepenies B, Weyd H and Krammer PH: Dectin-1 Binding to annexins on apoptotic cells induces peripheral immune tolerance via NADPH Oxidase-2. Cell Rep. 29:4435–4446.e9. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen R, Chen C, Han N, Guo W, Deng H, Wang Y, Ding Y and Zhang M: Annexin-1 is an oncogene in glioblastoma and causes tumour immune escape through the indirect upregulation of interleukin-8. J Cell Mol Med. 26:4343–4356. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Vacchelli E, Ma Y, Baracco EE, Sistigu A, Enot DP, Pietrocola F, Yang H, Adjemian S, Chaba K, Semeraro M, et al: Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science. 350:972–978. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Baracco EE, Stoll G, Van Endert P, Zitvogel L, Vacchelli E and Kroemer G: Contribution of annexin A1 to anticancer immunosurveillance. Oncoimmunology. 8:e16477602019. View Article : Google Scholar | |
|
Waldman AD, Fritz JM and Lenardo MJ: A guide to cancer immunotherapy: From T cell basic science to clinical practice. Nat Rev Immunol. 20:651–668. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shang Q, Yu X, Sun Q, Li H, Sun C and Liu L: Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy. Biomed Pharmacother. 170:1159762024. View Article : Google Scholar | |
|
Bretscher P: On Analyzing How the Th1/Th2 Phenotype of an immune response is determined: Classical observations must not be ignored. Front Immunol. 10:12342019. View Article : Google Scholar : PubMed/NCBI | |
|
Cvetanovich GL and Hafler DA: Human regulatory T cells in autoimmune diseases. Curr Opin Immunol. 22:753–760. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ohue Y and Nishikawa H: Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Cancer Sci. 110:2080–2089. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
D'Acquisto F, Paschalidis N, Sampaio AL, Merghani A, Flower RJ and Perretti M: Impaired T cell activation and increased Th2 lineage commitment in Annexin-1-deficient T cells. Eur J Immunol. 37:3131–3142. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Oshi M, Tokumaru Y, Mukhopadhyay S, Yan L, Matsuyama R, Endo I and Takabe K: Annexin A1 expression is associated with epithelial-mesenchymal transition (EMT), cell proliferation, prognosis and drug response in pancreatic cancer. Cells. 10:6532021. View Article : Google Scholar | |
|
Weyd H, Abeler-Dorner L, Linke B, Mahr A, Jahndel V, Pfrang S, Schnolzer M, Falk CS and Krammer PH: Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity. PLoS One. 8:e624492013. View Article : Google Scholar : PubMed/NCBI | |
|
Bai F, Zhang P, Fu Y, Chen H, Zhang M, Huang Q, Li D, Li B and Wu K: Targeting ANXA1 abrogates Tregmediated immune suppression in triplenegative breast cancer. J Immunother Cancer. 8:e0001692020. View Article : Google Scholar | |
|
Ishii G, Ochiai A and Neri S: Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Adv Drug Deliv Rev. 99:186–196. 2016. View Article : Google Scholar | |
|
Vaish U, Jain T, Are AC and Dudeja V: Cancer-Associated fibroblasts in pancreatic ductal adenocarcinoma: An update on heterogeneity and therapeutic targeting. Int J Mol Sci. 22:134082021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X and Song E: Turning foes to friends: Targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 18:99–115. 2019. View Article : Google Scholar | |
|
Kalluri R: The biology and function of fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Neymeyer H, Labes R, Reverte V, Saez F, Stroh T, Dathe C, Hohberger S, Zeisberg M, Muller GA, Salazar J, et al: Activation of annexin A1 signalling in renal fibroblasts exerts antifibrotic effects. Acta Physiol (Oxf). 215:144–158. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee S, Hong JH, Kim JS, Yoon JS, Chun SH, Hong SA, Kim EJ, Kang K, Lee Kang J, Ko YH, et al: Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells. Cancer Lett. 508:92–103. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Zhu S, Liu T, Zhang S, Lu J, Fan W, Lin L, Xiang T, Yang J, Zhao X, et al: Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell. 41:903–918. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Rong B, Zhao C, Liu H, Ming Z, Cai X, Gao W and Yang S: Elevated serum annexin A1 as potential diagnostic marker for lung cancer: A retrospective case-control study. Am J Transl Res. 6:558–569. 2014.PubMed/NCBI | |
|
Faria PC, Sena AA, Nascimento R, Carvalho WJ, Loyola AM, Silva SJ, Durighetto AF, Oliveira AD, Oliani SM and Goulart LR: Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients. Oral oncol. 46:25–30. 2010. View Article : Google Scholar | |
|
Han GH, Lu KJ, Huang JX, Zhang LX, Dai SB and Dai CL: Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma. J Cancer Res Ther. 14(Suppl): S667–S674. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Liu YS, Wu PF, Li Q, Dai WM, Yuan S, Xu ZH, Liu TT, Miao ZW, Fang WG, et al: Brain microvascular endothelium induced-annexin A1 secretion contributes to small cell lung cancer brain metastasis. Int J Biochem Cell Biol. 66:11–19. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE and Schnitzer JE: Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature. 429:629–635. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, Suzuki M, Hachinohe S, Ishiyama S, Nonaka M, et al: Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy. BMC cancer. 21:722021. View Article : Google Scholar | |
|
Hatakeyama S, Shibata TK, Tobisawa Y, Ohyama C, Sugihara K and Fukuda MN: Tumor targeting by a carbohydrate ligand-mimicking peptide. Methods Mol Biol. 1022:369–386. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Nonaka M, Suzuki-Anekoji M, Nakayama J, Mabashi-Asazuma H, Jarvis DL, Yeh JC, Yamasaki K, Akama TO, Huang CT, Campos AR, et al: Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours. Br J Cancer. 123:1633–1643. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Baracco EE, Petrazzuolo A and Kroemer G: Assessment of annexin A1 release during immunogenic cell death. Methods Enzymol. 629:71–79. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Arai H, Xiao Y, Loupakis F, Kawanishi N, Wang J, Battaglin F, Soni S, Zhang W, Mancao C, Salhia B, et al: Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer. J Immunother Cancer. 8:e0017142020. View Article : Google Scholar : PubMed/NCBI | |
|
Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G and Galluzzi L: Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death Dis. 11:10132020. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong W, Zhang B, Yu H, Zhu L, Yi L and Jin X: RRM2 Regulates sensitivity to sunitinib and PD-1 blockade in renal cancer by Stabilizing ANXA1 and Activating the AKT pathway. Adv Sci (Weinh). 8:21008812021. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao D, Zeng T, Zhu W, Yu ZZ, Huang W, Yi H, Lu SS, Feng J, Feng XP, Wu D, et al: ANXA1 promotes tumor immune evasion by binding PARP1 and upregulating Stat3-induced expression of PD-L1 in multiple cancers. Cancer Immunol Res. 11:1367–1383. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B, Wu X, Ma J, Zhou M, Li X, et al: Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. Mol Cancer. 18:102019. View Article : Google Scholar : PubMed/NCBI | |
|
Yu ZZ, Liu YY, Zhu W, Xiao D, Huang W, Lu SS, Yi H, Zeng T, Feng XP, Yuan L, et al: ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers. J Immunother Cancer. 11:e0063452023. View Article : Google Scholar : PubMed/NCBI | |
|
Stenfeldt AL, Karlsson J, Wennerås C, Bylund J, Fu H and Dahlgren C: Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation. 30:224–229. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yang SC, Chang SH, Hsieh PW, Huang YT, Ho CM, Tsai YF and Hwang TL: Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1. Free Radic Biol Med. 106:254–269. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Li Y, Han J, Zhu Z, Li M, Liu Q, Wang Y and Shi FD: Formyl peptide receptor 1 signaling potentiates inflammatory brain injury. Sci Transl Med. 13:eabe98902021. View Article : Google Scholar : PubMed/NCBI |
